PlainRecalls

Biomeme, Inc.

Compiled from official public sources by the publisher.

3 recalls on record · Latest: Jan 12, 2022

Subscribe to new Biomeme, Inc. recalls (RSS)

Agency notice ledger

Federal filing book Biomeme, Inc. LIGHT-BOOK · SINGLE-AGENCY

#3,407 of 14,151 · 3 notices · 0.003% archive

  • BOOK 3 notices
  • RANK #3,407 of 14,151
  • SHARE 0.003% archive
  • AGENCY FDA Devices (3)
  • CAT medical devices
  • CATS 1 category
  • LATEST Jan 12, 2022
  • PHOTO 3B Medical, Inc.

Nearest notice-volume peer: 3B Medical, Inc. (0 notice gap)

Biomeme, Inc. accounts for about 0.003% of the 104,423-notice archive on 3 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Where Biomeme, Inc. sits among 14,151 recalling firms

Biomeme, Inc. ranks 3,407th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Biomeme, Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

3 3407th of 14151 higher than 9,908 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Biomeme, Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Biomeme, Inc. holds about 0.003% of archive notices alongside 3 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Devices Moderate Jan 12, 2022

Biomeme SARS-CoV-2- Real Time RT-PCR Test, Instructions for Use, Part number 100002824 Subcomponent of: SARS-CoV-2 Go-Strips, 3000555; SARS-CoV-2 Go-Plates, 3000562; SARS-Cov-2 Bulk Vials, 3000564
FDA Devices Low Feb 10, 2021

Nucleic acid-based in vitro diagnostic devices for the detection of 2019-novel coronavirus (2019-nCoV) and/or diagnosis of 2019-nCoV infection in human clinical specimens. The RT-PCR test runs on a Franklin Real-Time PCR Thermocycler Device (Reference/Catalog Number 1000003,1000018) with the Software Controller version 6.4.3. The cycler has a "baseboard" unit with firmware and associated software component that control motorized movements of the optical filter carriage used for PCR detection.
FDA Devices Moderate Dec 9, 2020

The Biomeme SARS-CoV-2 Real-Time RT-PCR Test is a molecular in vitro diagnostic test that is based on widely used nucleic acid amplification technology. The Biomeme SARS-CoV-2 Real-Time RT-PCR Test contains primers and probes and internal controls used in RT-PCR for the in vitro qualitative detection of SARS-CoV-2 RNA in upper respiratory specimens. The Biomeme SARS-CoV-2 Real-Time RT-PCR Test utilizes Biomemes M1 Sample Prep Cartridge for RNA extraction, Biomemes SARS-CoV-2 Go-Strips assay, a

Biomeme, Inc. is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (3 here).

3B Medical, Inc. 3 7-Eleven, Inc. 3 A & C Best Food Trading 3 A B Nutrition, Inc. 3 A L I Technologies Ltd 3

Similar medical devices volume

Nearest multi-notice firms in the same narrow category lane.

3B Medical, Inc. 3 A L I Technologies Ltd 3 Abeon Medical Corporation 3 Acist Medical Systems 3

Frequently Asked Questions

How many federal recall notices name Biomeme, Inc.? ▼
PlainRecalls indexes 3 distinct federal recall events naming Biomeme, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Biomeme, Inc. sit among other recalling firms? ▼
Biomeme, Inc. ranks #3,407 of 14,151 by distinct recall-event count among 14,151 firms in this archive (70th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Biomeme, Inc.'s notices? ▼
FDA Devices accounts for 3 of this firm's 3 indexed notices.
What product category dominates Biomeme, Inc.'s filing book? ▼
Filings for Biomeme, Inc. span 1 product category, led by medical devices. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Biomeme, Inc.: 3 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Devices). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Biomeme, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026